Abstract
The history and the behavioral profile of 2 patients with brain abnormalities in the region of the left amygdaloidal complex might suggest that the dysfunction of the neural pathways related to the left amygdala has to occur at an early developmental stage to result in impaired emotional judgments of facial expressions. This is in line with the hypothesis that emotional information processing is based on a distributed neural network which, during ontogenesis, gradually expands from the amygdala and the amygdaloidal complex to further components of the limbic system.
References
1.
Mark LP, Daniels DL, Naidich TP, Hendrix LE: Limbic connections. Am J Neuroradiol 1995;16:1303-1306.
2.
Papez JW: A proposed mechanism of emotion. 1937. J Neuropsychiatry Clin Neurosci 1995;7:103-112.
3.
Adolphs R, Tranel D, Damasio H, Damasio A: Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala. Nature 1994;372:669-672.
4.
Markowitsch HJ, Calabrese P, Würker M, Durwen HF, Kessler J, Babinsky R, et al: The amygdala's contribution to memory - a study on two patients with Urbach-Wiethe disease. Neuroreport 1994;5:1349-1352.
5.
Siebert M, Markowitsch HJ, Bartel P: Amygdala, affect and cognition: evidence from 10 patients with Urbach-Wiethe disease. Brain 2003;126:2627-2637.
6.
Morris JS, Frith CD, Perrett DI, Rowland D, Young AW, Calder AJ, et al: A differential neural response in the human amygdala to fearful and happy facial expressions. Nature 1996;383:812-815.
7.
LeDoux J: Emotional networks and motor control: a fearful view. Progr Brain Res 1996;107:437-446.
8.
Gallagher M, Holland PC: The amygdala complex: multiple roles in associative learning and attention. Proc Natl Acad Sci USA 1994;91:11771-11776.
9.
Sabatinelli D, Fortune EE, Li Q, Siddiqui A, Krafft C, Oliver WT, et al: Emotional perception: meta-analyses of face and natural scene processing. Neuroimage 2011;54:2524-2533.
10.
Breiter HC, Etcoff NL, Whalen PJ, Kennedy WA, Rauch SL, Buckner RL, et al: Response and habituation of the human amygdala during visual processing of facial expression. Neuron 1996;17:875-887.
11.
Phillips ML, Young AW, Scott SK, Calder AJ, Andrew C, Giampietro V, et al: Neural responses to facial and vocal expressions of fear and disgust. Proc Biol Sci 1998;265:1809-1817.
12.
Calder AJ, Lawrence AD, Young AW: Neuropsychology of fear and loathing. Nat Rev Neurosci 2001;2:352-363.
13.
Zald DH: The human amygdala and the emotional evaluation of sensory stimuli. Brain Res Brain Res Rev 2003;41:88-123.
14.
Adolphs R, Sears L, Piven J: Abnormal processing of social information from faces in autism. J Cogn Neurosci 2001;13:232-240.
15.
Grelotti DJ, Gauthier I, Schultz RT: Social interest and the development of cortical face specialization: what autism teaches us about face processing. Dev Psychobiol 2002;40:213-225.
16.
Critchley HD, Daly EM, Bullmore ET, Williams SC, Van Amelsvoort T, Robertson DM, et al: The functional neuroanatomy of social behaviour: changes in cerebral blood flow when people with autistic disorder process facial expressions. Brain 2000;123:2203-2212.
17.
Whalen PJ, Rauch SL, Etcoff NL, McInerney SC, Lee MB, Jenike MA: Masked presentations of emotional facial expressions modulate amygdala activity without explicit knowledge. J Neurosci 1998;18:411-418.
18.
Cristinzio C, N'Diaye K, Seeck M, Vuilleumier P, Sander D: Integration of gaze direction and facial expression in patients with unilateral amygdala damage. Brain 2010;133:248-261.
19.
Young AW, Aggleton JP, Hellawell DJ, Johnson M, Broks P, Hanley JR: Face processing impairments after amygdalotomy. Brain 1995;118:15-24.
20.
Young AW, Hellawell DJ, Van De Wal C, Johnson M: Facial expression processing after amygdalotomy. Neuropsychologia 1996;34:31-39.
21.
Hamann SB, Adolphs R: Normal recognition of emotional similarity between facial expressions following bilateral amygdala damage. Neuropsychologia 1999;37:1135-1141.
22.
Tsuchiya N, Moradi F, Felsen C, Yamazaki M, Adolphs R: Intact rapid detection of fearful faces in the absence of the amygdala. Nat Neurosci 2009;12:1224-1225.
23.
Härting C, Markowitsch H, Neufeld H, Calabrese P, Deiseinger K, Kessler J: Wechsler Memory Scale - Revised. German Version. Bern, Huber 2000.
24.
Bradley MM, Lang PJ: The International Affective Picture System (IAPS) in the study of emotion and attention; in Coan JA, Allen JJB (eds): Handbook of Emotion Elicitation and Assessment. New York, Oxford University Press, 2007, pp 29-46.
25.
Hamann SB, Stefanacci L, Squire LR, Adolphs R, Tranel D, Damasio H, et al: Recognizing facial emotion. Nature 1996;379:497.
26.
Goldstein K: The Organism: A Holistic Approach to Biology Derived from Pathological Data in Man. New York, Zone Books, 1995.
27.
Hamann SB, Monarch ES, Goldstein FC: Memory enhancement for emotional stimuli is impaired in early Alzheimer's disease. Neuropsychology 2000;14:82-92.
28.
Maheu FS, Dozier M, Guyer AE, Mandell D, Peloso E, Poeth K, et al: A preliminary study of medial temporal lobe function in youths with a history of caregiver deprivation and emotional neglect. Cogn Affect Behav Neurosci 2010;10:34-49.
29.
Tottenham N, Hare TA, Millner A, Gilhooly T, Zevin JD, Casey BJ: Elevated amygdala response to faces following early deprivation. Dev Sci 2011;14:190-204.
30.
Sebastian CL, McCrory EJP, Cecil CAM, Lockwood PL, De Brito SA, Fontaine NMG, et al: Neural responses to affective and cognitive theory of mind in children with conduct problems and varying levels of callous-unemotional traits. Arch Gen Psychiatry 2012;69:814-822.
31.
Gee DG, Karlsgodt KH, Van Erp TGM, Bearden CE, Lieberman MD, Belger A, et al: Altered age-related trajectories of amygdala-prefrontal circuitry in adolescents at clinical high risk for psychosis: a preliminary study. Schizophr Res 2012;134:1-9.
32.
Swartz JR, Wiggins JL, Carrasco M, Lord C, Monk CS: Amygdala habituation and prefrontal functional connectivity in youth with autism spectrum disorders. J Am Acad Child Adolesc Psychiatry 2013;52:84-93.
33.
Szeszko PR, MacMillan S, McMeniman M, Lorch E, Madden R, Ivey J, et al: Amygdala volume reductions in pediatric patients with obsessive-compulsive disorder treated with paroxetine: preliminary findings. Neuropsychopharmacology 2004;29:826-832.
34.
Lim CS, Baldessarini RJ, Vieta E, Yucel M, Bora E, Sim K: Longitudinal neuroimaging and neuropsychological changes in bipolar disorder patients: review of the evidence. Neurosci Biobehav Rev 2013;37:418-435.
35.
Feinstein JS, Buzza C, Hurlemann R, Follmer RL, Dahdaleh NS, Coryell WH, et al: Fear and panic in humans with bilateral damage. Nat Neurosci 2013;16:270-272.
36.
Sergerie K, Chocol C, Armony JL: The role of amygdala in emotional processing: a quantitative meta-analysis of functional neuroimaging studies. Neurosci Biobehav Rev 2008;32:811-830.
37.
Vrtička P, Sander D, Vuilleumier P: Lateralized interactive social content and valence processing within the human amygdala. Front Hum Neurosci 2012;6:358.
38.
Becker B, Mihov Y, Scheele D, Kendrick KM, Feinstein JS, Matusch A, et al: Fear processing and social networking in the absence of a functional amygdala. Biol Psychiatry 2012;72:70-77.
39.
Mihov Y, Kendrick KM, Becker B, Zschernack J, Reich H, Maier W, et al: Mirroring fear in the absence of a functional amygdala. Biol Psychiatry 2013;73:e9-e11.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.